#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	8088	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2075	385.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	412	C	407	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	427.2	0	.	n	.	0	T695C	SNP	695	695	T	1032	1032	C	447	C,T	438,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	427.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1674	1674	A	508	A,G	502,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	427.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2308	2308	C	497	C	485	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	427.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2382	2382	A	479	A	475	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	15558	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	427.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2934	2934	C	473	C,T	469,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	V36A	NONSYN	106	108	GTG	447	449	GCG	106;106;109	G;C;G	105;105;109	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	489	491	CGG	116;116;116	C;G;G	116;114;115	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	S68L	NONSYN	202	204	TCG	543	545	TTG	100;100;97	T;T;G	91;99;94	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	A90V	NONSYN	268	270	GCG	609	611	GTT	99;100;101	G;T;T	97;91;96	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	I105V	NONSYN	313	315	ATT	654	656	GTT	94;94;94	G;T,C;T	93;88,1;93	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	N125T	NONSYN	373	375	AAT	714	716	ACC	81;80;81	A;C;C	77;77;78	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	R135C	NONSYN	403	405	CGT	744	746	TGT	86;88;88	T;G;T	76;86;86	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	K151E	NONSYN	451	453	AAA	792	794	GAA	79;80;79	G;A;A	78;79;78	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	795	797	AAC	80;80;79	A;A;C	79;79;78	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	A172T	NONSYN	514	516	GCG	855	857	ACA	73;71;71	A;C;A	71;71;70	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	A175E	NONSYN	523	525	GCG	864	866	GAA	71;73;74	G;A;A	69;72;72	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	E176T	NONSYN	526	528	GAA	867	869	ACC	76;77;78	A;C;C	72;75;77	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	I178V	NONSYN	532	534	ATC	873	875	GTC	75;75;74	G;T;C	75;75;74	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	I188T	NONSYN	562	564	ATA	903	905	ACG	79;82;81	A;C;G	77;80;80	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	P200N	NONSYN	598	600	CCC	939	941	AAC	76;76;76	A;A;C	76;73;75	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	F220L	NONSYN	658	660	TTT	999	1001	TTG	85;85;84	T;T;G,A	85;85;83,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1056	1058	ACC	70;70;71	A,G;C,A;C,G	67,1;69,1;69,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1059	1061	GAC	72;73;74	G;A;C	71;68;74	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1068	1070	GCG	71;71;72	G;C;G	68;59;69	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1104	1106	GCT	57;59;61	G;C;T	57;57;54	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	936	folP	858	858	91.61	folP.l15.c4.ctg.1	1520	61.3	1	SNP	p	R230S	1	.	.	688	690	AGC	1029	1031	AGC	82;82;80	A;G;C	82;82;78	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3196	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3389	93.7	1	SNP	p	S91F	0	.	.	271	273	TCC	605	607	TCC	112;112;113	T;C;C	111;112;113	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3196	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3389	93.7	1	SNP	p	D95G	0	.	.	283	285	GAC	617	619	GAC	110;109;109	G;A;C	109;108;109	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3196	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3389	93.7	1	SNP	p	D95N	0	.	.	283	285	GAC	617	619	GAC	110;109;109	G;A;C	109;108;109	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	978	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1324	73.1	1	SNP	p	G45D	1	.	.	133	135	GAC	461	463	GAC	128;127;125	G;A,G;C	123;119,2;121	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	468	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1131	40.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2822	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	95.4	1	SNP	p	D86N	0	.	.	256	258	GAC	533	535	GAC	133;133;132	G;A;C	128;126;127	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2822	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	95.4	1	SNP	p	S87I	0	.	.	259	261	AGT	536	538	AGT	132;131;131	A;G;T	127;125;124	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2822	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	95.4	1	SNP	p	S87W	0	.	.	259	261	AGT	536	538	AGT	132;131;131	A;G;T	127;125;124	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2822	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	95.4	1	SNP	p	S87R	0	.	.	259	261	AGT	536	538	AGT	132;131;131	A;G;T	127;125;124	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2822	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2935	95.4	1	SNP	p	S88P	0	.	.	262	264	TCC	539	541	TCC	130;131;129	T;C;C	124;125;125	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2236	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2625	84.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1549	1551	GGC	110;109;108	G;G;C	106;105;106	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1284	1286	GCC	121;121;122	G;C;C	120;119;121	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1287	1289	ATG	121;121;120	A;T;G	119;120;119	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1299	1301	ACC	118;118;116	A;C;C	111;117;114	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1299	1301	ACC	118;118;116	A;C;C	111;117;114	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1800	1802	ACC	85;85;83	A;C;C	80;84;81	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1854	1856	GCG	94;97;99	G;C;G	94;97;98	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1854	1856	GCG	94;97;99	G;C;G	94;97;98	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1977	1979	GGT	87;84;81	G,T;G;T	84,1;84;78	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1986	1988	AGC	75;75;73	A;G;C	71;74;72	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2240	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2531	87.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2004	2006	CCG	57;58;59	C;C;G,C	51;53;48,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3110	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3185	97.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1382	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1814	75.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	555	555	C	92	C,G	86,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	160	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	574	12.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	331	333	AAT	12;12;12	A;A;T	12;11;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	160	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	574	12.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	334	336	AAT	12;12;12	A;A;T	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	160	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	574	12.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	358	360	GCA	11;11;11	G;C;A	11;11;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	160	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	574	12.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	381	383	GTA	11;11;11	G;T;A	11;10;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	160	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	574	12.3	0	.	p	.	0	S236N	NONSYN	706	708	AGC	387	389	AAC	11;10;10	A;A;C	11;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	160	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	574	12.3	0	.	p	.	0	N237M	NONSYN	709	711	AAC	390	392	ATG	10;10;10	A;T;G	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	160	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	574	12.3	0	.	p	.	0	D238fs	FSHIFT	712	712	G	393	393	G	13	G	13	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1596	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1585	99.5	0	.	p	.	0	E41K	NONSYN	121	123	GAA	437	439	AAA	125;123;123	A,G;A;A	122,1;121;122	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1596	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1585	99.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	947	947	T	118	T	111	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1596	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1585	99.5	1	SNP	p	G120K	0	.	.	358	360	GGT	674	676	GGT	123;123;126	G,A;G,A;T,G	120,1;120,1;116,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1596	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1585	99.5	1	SNP	p	A121N	0	.	.	361	363	GCC	677	679	GCC	127;127;127	G,A;C,A;C	124,1;124,1;125	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1596	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1585	99.5	1	SNP	p	A121D	0	.	.	361	363	GCC	677	679	GCC	127;127;127	G,A;C,A;C	124,1;124,1;125	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	5384	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5014	106.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2127	2129	CAT	107;107;108	C;A;T	105;106;106	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	624	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	986	62.6	1	SNP	p	V57M	1	.	.	169	171	ATG	451	453	ATG	130;131;128	A;T;G	128;128;127	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
